776 results on '"Idzko, Marco"'
Search Results
2. Correction: Positionspapier der ÖGR und ÖGP zur Diagnose und Therapie der Sarkoidose 2024
3. Nebulized alteplase in coronavirus disease 2019 pneumonia: a case series
4. Evaluation of PD-1 and interleukin-10-receptor expression by T lymphocytes in malignant and benign pleural effusions
5. Geschlechtsspezifische Aspekte bei Asthma bronchiale
6. Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s
7. The Impact of Smoking History on Baseline Characteristic in Patients With Severe Asthma in the German Asthma Net (GAN)
8. Impact of Smoking on Biological Treatment Response in Patients From the German Severe Asthma (GAN) Registry
9. Primary Ciliary Dyskinesia in Adult Bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS
10. Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
11. Wenn die trockene Nase zur Lungenerkrankung führt …
12. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
13. Characterization of Obesity in Severe Asthma in the German Asthma Net
14. Characterization of Austrian severe asthma patients
15. Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP
16. German Asthma Net – Was haben wir bisher gelernt?
17. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
18. Immune cell profiles and patient clustering in complex cases of interstitial lung disease
19. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
20. Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP)
21. Lack of adipocyte purinergic P2Y₆ receptor greatly improves whole body glucose homeostasis
22. Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
23. Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation
24. P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction
25. New insights from GINA 2019/2020—Focus on early anti-inflammatory therapy
26. Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines
27. German asthma net: Nasal polyposis in patients in the severe asthma registry.
28. Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data
29. Toward personalization of asthma treatment according to trigger factors
30. Evaluation of PD-1 and interleukin-10-receptor expression by T lymphocytes in malignant and benign pleural effusions
31. Relevanz homologer Allergene bei der spezifischen Immuntherapie von Pollenallergien: Statement des Standeskomitees klinische Allergologie der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)
32. Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020): Statement of the Austrian Society of Pneumology (ASP)
33. Primary Ciliary Dyskinesia in Adult Bronchiectasis
34. Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions
35. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
36. Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of an inhaled recombinant human ACE2
37. Purinergic Signaling: A New Pharmacological Target Against Viruses?
38. P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation
39. Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
40. Blocking P2Y2 purinergic receptor prevents the development of lipopolysaccharide-induced acute respiratory distress syndrome
41. Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
42. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study
43. Feasibility of a Supraglottic Airway Device for Transbronchial Lung Cryobiopsy—A Retrospective Analysis
44. Low-dose and standard-dose whole-body [18F]FDG-PET/CT imaging: implications for healthy controls and lung cancer patients.
45. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients
46. Cell-type-specific role of P2Y2 receptor in HDM-driven model of allergic airway inflammation
47. Clinical utility of routine bronchoscopic secretion sampling for microbiological and multiplex PCR during bronchoscopy
48. UNCOVER – a non-interventional study to investigate undiagnosed severe asthma in Austria
49. Evaluation of PD-1 T lymphocytes in bronchoalveolar lavage in lung cancer compared to benign lung diseases
50. Response to biologics and clinical remission in the adult GAN severe asthma cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.